The JBT Marel Corporation (JBTM) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a New York Stock Exchange–listed issuer, JBT Marel files documents that cover its financial condition, capital structure, governance changes, and material events related to its operations as a global technology solutions provider to high-value segments of the food and beverage industry.
Among the key filings, investors can review Form 8-K reports that describe significant developments. Recent 8-K filings have addressed topics such as quarterly financial results, changes in principal accounting officers, amendments to the company’s credit agreement, and the entry into and closing of a private offering of convertible senior notes due 2030. These filings also outline the terms of the notes, including interest rate, maturity, conversion features, and related convertible note hedge and warrant transactions, as well as the impact on the company’s capital structure.
JBT Marel’s filings further document its transition from John Bean Technologies Corporation to JBT Marel Corporation, the acquisition of Marel hf., and the integration of the combined business. Pro forma financial information and management’s discussion and analysis related to the Marel transaction have been provided in connection with capital markets offerings, giving additional context on the combined company’s financial profile and segment structure.
On Stock Titan, these SEC filings are complemented by AI-powered summaries that help explain the significance of complex documents. Users can quickly understand the main points of 8-Ks, as well as locate annual and quarterly reports such as Forms 10-K and 10-Q when available. The platform also surfaces information relevant to direct financial obligations, unregistered sales of equity securities, and other events disclosed under specific SEC items. This makes it easier to track how JBT Marel reports on its financing activities, governance changes, and integration progress over time.
JBT Marel Corporation reported a sharp turnaround for the three months ended March 31, 2026, with revenue of $936 million, up 9.6% from 2025, and net income of $45 million versus a prior-year loss of $173 million. Gross margin improved to 35.1% as synergy benefits and higher volumes more than offset higher tariff costs.
Selling, general and administrative expenses fell significantly, aided by the JBT Marel 2025 Integration restructuring plan and lower M&A costs. Adjusted EBITDA rose to $142 million with a 15.2% margin. Operating cash flow strengthened to $119 million, and free cash flow reached $100 million. Total debt stood at $1.84 billion, including convertible notes maturing in 2026 and 2030, while cash and cash equivalents were $211 million.
JBT Marel Corporation reported strong first quarter 2026 results and reiterated its full-year 2026 outlook. Revenue rose 10% to $936 million, with orders above $1 billion and a book-to-bill ratio of 1.14x. Net income was $45 million, reversing a $173 million loss a year earlier, and diluted EPS was $0.86 versus a $3.35 loss. Adjusted EPS increased to $1.58 from $0.97, and adjusted EBITDA grew to $142 million, a 15.2% margin. Free cash flow reached $100 million, reducing net debt to trailing twelve months adjusted EBITDA to 2.6x. Protein Solutions drove growth with 22% higher revenue and a 21.7% adjusted EBITDA margin, while Prepared Food and Beverage Solutions revenue was flat and margin softened. For full year 2026, the company continues to guide revenue of $3.99–$4.07 billion, net income margin of 6.1%–6.6%, adjusted EBITDA margin of 17.0%–17.5%, GAAP diluted EPS of $4.70–$5.15, and adjusted EPS of $8.00–$8.50, including anticipated restructuring, M&A, and acquisition-related amortization costs.
Vanguard Capital Management reported beneficial ownership of 2,727,805 shares of JBT Marel Corp common stock, representing 5.24% of the class as of 03/31/2026. The filing states Vanguard has sole voting power over 397,955 shares and sole dispositive power over 2,727,805 shares. The report clarifies these holdings include securities held for Vanguard funds and managed accounts and lists Vanguard affiliates that exercise voting or dispositive authority. Signature block shows the filing was signed by Ashley Grim on 04/30/2026.
JBT Marel Corp ownership disclosure: Vanguard Portfolio Management reports beneficial ownership of 2,846,591 shares of Common Stock, representing 5.47% of the class as of 03/31/2026. The filing states Vanguard Portfolio Management LLC and affiliated business divisions exercise dispositive power over these shares.
JBT Marel Corporation is asking stockholders to vote at its 2026 virtual annual meeting on three main items: re‑electing ten directors for one-year terms, an advisory “say on pay” vote on executive compensation, and ratifying PricewaterhouseCoopers LLC as independent auditor for 2026.
The proxy highlights 2025 as a transformational year following the combination of John Bean Technologies and Marel. Total 2025 revenue was $3,798.2 million, with adjusted income from continuing operations of $333.1 million and adjusted EBITDA of $600.4 million. GAAP results show a $49.7 million loss from continuing operations.
The company reports de‑levering its balance sheet to a financial leverage ratio below 2.9x and emphasizes a pay-for-performance design: about 87% of the CEO’s and 69% of other named executives’ 2025 target compensation is at risk, heavily tied to adjusted EBITDA, EBITDA margin, leverage reduction, adjusted EPS, and ROIC over multi‑year periods.
JBT Marel Corp filing: The Vanguard Group amended its Schedule 13G to report that, after an internal realignment, certain Vanguard subsidiaries will report beneficial ownership separately. The filing states amount beneficially owned: 0 and percent of class: 0% as disclosed in the amendment.
The amendment cites SEC Release No. 34-39538 and notes that Vanguard subsidiaries pursue the same investment strategies and that The Vanguard Group, Inc. no longer is deemed to beneficially own the securities held by those subsidiaries.
JBT Marel Corporation is using its 2026 Investor Day to lay out a long‑term growth and margin story after the JBT–Marel combination. Management highlights 2025 revenue of $3.8B with an Adjusted EBITDA margin of 15.8%, split between Protein Solutions and Prepared Food and Beverage Solutions.
The company targets organic revenue growth of 5–7% annually through 2028, driven by secular food and beverage demand, cross‑selling and integrated line solutions. It aims to lift Adjusted EBITDA margin to 20%, generate free cash flow equal to 55–60% of Adjusted EBITDA, realize about $150M of annual run‑rate cost synergies by 2027, and operate with leverage in the 2.0–2.5% range of net debt to Adjusted EBITDA.
JBT MAREL Corp CEO Brian A. Deck sold common stock in two open-market transactions. On March 3, 2026, he sold 8,634 shares at an average price of $150.51 per share. On March 2, 2026, he sold an additional 10,000 shares at $151.39 per share.
These were direct sales of non-derivative common stock, leaving Deck with 127,667 shares owned directly after the most recent transaction.
Brian Deck reported a sale of 10,000 common shares on 03/02/2026, recorded at $1,513,900.00 on the Form 144 filing. The filing also lists prior and upcoming restricted stock vesting awards that total 8,634 shares across specific vesting dates in 2021, 2022 and 2025.
The sale appears as a standard Form 144 notice of intended sale; timing and further disposition details beyond the reported sale date and amount are not included in the excerpt.